A significant breakthrough in cancer investigation is occurring with the use of mini-antibodies to restore dysfunctional p53. This essential tumor protector protein is frequently disabled in various types of tumors, https://sociallawy.com/story12573211/vhh-fragments-restore-p53-a-potential-pathway-for-tumor-management